SCHEMBL7554427

SCHEMBL7554427

Cc1ccc(NC2=CC(=O)SC2)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 1/20 0.46
ALDH1A1 P00352 6/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 4/20 0.42
KDM4E B2RXH2 1/20 0.42
POLB P06746 1/20 0.42
DHODH Q02127 2/20 0.41
HTT P42858 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
FKBP1A P62942 1/20 0.40
TSHR P16473 1/20 0.40
GAA P10253 2/20 0.39
APAF1 O14727 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7517108 0.83 MEN1 (0.38) ALDH1A1MEN1KMT2APOLBDHODH
SCHEMBL7525033 0.82 RAB9A (0.56) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL7558368 0.80 P2RX3 (0.38) MEN1KMT2AMAPTPOLBDHODH
SCHEMBL7560746 0.78 KDM4E (0.46) RAPGEF4ALDH1A1MEN1KMT2AMAPT
SCHEMBL7524238 0.73 RAPGEF4 (0.46) RAPGEF4ALDH1A1MEN1KMT2AMAPT
SCHEMBL9513146 0.71 RAPGEF4 (0.68) RAPGEF4ALDH1A1MEN1KMT2AMAPT
SCHEMBL7518438 0.69 EPHX1 (0.61) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL7522460 0.66 MAPT (0.42) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL28736208 0.66 MAPT (0.59) RAPGEF4ALDH1A1MEN1KMT2AMAPT
SCHEMBL29633284 0.66 MAPT (0.59) RAPGEF4ALDH1A1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173420-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2002-01-23 EP disclosed
WO-2000053581-A2 HETEROCYCLIC COMPOUNDS HAVING ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2000-09-14 WO disclosed